Amira Hussein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amira Hussein has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Mona Hafez
Pediatric cardiology Unit, Faculty of Medicine, Mansoura University, Mansoura, Egypt
3 shared publications- Ayman Hammad
Pediatric nephrology Unit, Faculty of medicine, Mansoura University, Mansoura, Egypt
2 shared publications John Nigro
Division of Cardiology, Rady Children's Hospital-San Diego, San Diego, California
2 shared publications- Mai S. Korkor
Pediatric nephrology Unit, Faculty of medicine, Mansoura University, Mansoura, Egypt
2 shared publications - Shaimaa Rakha
Pediatric cardiology Unit, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2 shared publications - Srujan Ganta
Cardiothoracic Surgery, Rady Children's Hospital San Diego, San Diego, CA, USA
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (12) , 927
Pulmonary involvement in Gaucher disease patients receiving enzyme replacement therapy: a cross-sectional analysis of radiological and functional lung abnormalities
Pulmonary involvement in Gaucher disease (GD) is underrecognized and may range from asymptomatic radiological abnormalities to respiratory impairment. This study assessed pulmonary involvement and its associations with disease phenotype, genotype, and pulmonary function in patients receiving long-term enzyme replacement therapy (ERT). In this single-center cross-sectional study, 52 genetically confirmed patients with GD receiving ERT underwent clinical assessment and high-resolution computed tomography (HRCT). Spirometry was performed in 34 cooperative patients aged ≥ 6 years. Clinical characteristics, genotype, baseline glucosylsphingosine (lyso-GL1), and disease phenotype were analyzed in relation to pulmonary findings. Respiratory symptoms were present in 19/52 (36.5%) patients. HRCT demonstrated interstitial abnormalities suggestive of interstitial lung disease (ILD) in 24/52 (46.2%), predominantly ground-glass opacities and interstitial thickening. These abnormalities were more frequent in type 3 than type 1 GD ( P = 0.001). Homozygous L483P was associated with HRCT abnormalities suggestive of ILD in univariable analysis ( P = 0.013). Among 34 patients undergoing spirometry, 11 (32.4%) had abnormal results, including obstructive (8.8%), restrictive (11.8%), and mixed (11.8%) patterns. Abnormal spirometry was associated with HRCT abnormalities ( P < 0.001), while three patients had radiological abnormalities despite preserved spirometry. On multivariable analysis, higher baseline lyso-GL1, type 3 phenotype, and kyphoscoliosis were independently associated with HRCT abnormalities suggestive of ILD. Conclusion : Pulmonary abnormalities remained common despite long-term ERT, particularly in type 3 GD. HRCT detected interstitial abnormalities in some patients with preserved spirometry, suggesting that structural pulmonary involvement may precede functional impairment. Individualized respiratory surveillance should be considered, particularly in patients with type 3 GD. What is Known :• Pulmonary involvement in Gaucher disease ranges from subclinical radiological abnormalities to respiratory impairment and is more frequent in type 3 disease. Its relationship with genotype and lung function remains incompletely defined . What is New :• Pulmonary abnormalities were frequent despite long-term enzyme replacement therapy, particularly in type 3 disease. HRCT detected interstitial abnormalities in patients with normal spirometry, while type 3 phenotype, higher baseline lyso-GL1, and kyphoscoliosis independently predicted pulmonary involvement .
- 10 November 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (12) , 927
Open AccessPulmonary involvement in Gaucher disease patients receiving enzyme replacement therapy: a cross-sectional analysis of radiological and functional lung abnormalities
Pulmonary involvement in Gaucher disease (GD) is underrecognized and may range from asymptomatic radiological abnormalities to respiratory impairment. This study assessed pulmonary involvement and its associations with disease phenotype, genotype, and pulmonary function in patients receiving long-term enzyme replacement therapy (ERT). In this single-center cross-sectional study, 52 genetically confirmed patients with GD receiving ERT underwent clinical assessment and high-resolution computed tomography (HRCT). Spirometry was performed in 34 cooperative patients aged ≥ 6 years. Clinical characteristics, genotype, baseline glucosylsphingosine (lyso-GL1), and disease phenotype were analyzed in relation to pulmonary findings. Respiratory symptoms were present in 19/52 (36.5%) patients. HRCT demonstrated interstitial abnormalities suggestive of interstitial lung disease (ILD) in 24/52 (46.2%), predominantly ground-glass opacities and interstitial thickening. These abnormalities were more frequent in type 3 than type 1 GD ( P = 0.001). Homozygous L483P was associated with HRCT abnormalities suggestive of ILD in univariable analysis ( P = 0.013). Among 34 patients undergoing spirometry, 11 (32.4%) had abnormal results, including obstructive (8.8%), restrictive (11.8%), and mixed (11.8%) patterns. Abnormal spirometry was associated with HRCT abnormalities ( P < 0.001), while three patients had radiological abnormalities despite preserved spirometry. On multivariable analysis, higher baseline lyso-GL1, type 3 phenotype, and kyphoscoliosis were independently associated with HRCT abnormalities suggestive of ILD. Conclusion : Pulmonary abnormalities remained common despite long-term ERT, particularly in type 3 GD. HRCT detected interstitial abnormalities in some patients with preserved spirometry, suggesting that structural pulmonary involvement may precede functional impairment. Individualized respiratory surveillance should be considered, particularly in patients with type 3 GD. What is Known :• Pulmonary involvement in Gaucher disease ranges from subclinical radiological abnormalities to respiratory impairment and is more frequent in type 3 disease. Its relationship with genotype and lung function remains incompletely defined . What is New :• Pulmonary abnormalities were frequent despite long-term enzyme replacement therapy, particularly in type 3 disease. HRCT detected interstitial abnormalities in patients with normal spirometry, while type 3 phenotype, higher baseline lyso-GL1, and kyphoscoliosis independently predicted pulmonary involvement .
- Open Access
- 19 September 2026
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 52 (1) , 141
Evaluating the myocardial functions of the forgotten right ventricle in children with nephrotic syndrome utilizing traditional echocardiography, two-dimensional speckle tracking and three-dimensional echocardiography
Background: Primary nephrotic syndrome (NS) is associated with systemic effects that may impact cardiac function, although several studies have explored left ventricle in children with NS. Few studies investigated right ventricle (RV) in this disease. Therefore, the study aimed to provide a comprehensive evaluation of RV functions in children with primary NS using echocardiography. Methods: A case-control observational study was conducted from January 2022 to August 2024 on 40 primary NS patients with steroid-resistant nephrotic syndrome (SRNS) and steroid-sensitive nephrotic syndrome (SSNS), alongside 40 healthy controls. All participants underwent RV assessments using conventional parameters, tissue Doppler imaging (TDI), two-dimensional speckle-tracking echocardiography (2D STE), and three-dimensional echocardiography (3DE). Results: Significantly lower s’, e’ in NS patients compared to controls, especially lower in SRNS compared to SSNS. Significantly higher E/e’ and Tei index was detected in the NS group compared to controls (p = < 0.001) and more pronounced in SRNS. RV free wall strain longitudinal strain (RVFWLS) and RV four chamber longitudinal strain (RV4CSL) were significantly reduced in NS group compared to controls. 3D auto RV-derived ejection fraction (EF), TAPSE, stroke volume and septal strain were lower in NS compared to controls(p = < 0.001); however, there are no significant differences between SSNS and SRNS. Significant correlations were detected between some echocardiographic parameters and serum cholesterol, albumin, and creatinine. Conclusions: Integrative use of variable echocardiographic modalities allows detection of subclinical alterations in RV function in children with primary NS, with more affected parameters in SRNS. Therefore, regular surveillance of RV functions in primary NS should be considered.
- 19 September 2026
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 52 (1) , 141
Open AccessEvaluating the myocardial functions of the forgotten right ventricle in children with nephrotic syndrome utilizing traditional echocardiography, two-dimensional speckle tracking and three-dimensional echocardiography
Background: Primary nephrotic syndrome (NS) is associated with systemic effects that may impact cardiac function, although several studies have explored left ventricle in children with NS. Few studies investigated right ventricle (RV) in this disease. Therefore, the study aimed to provide a comprehensive evaluation of RV functions in children with primary NS using echocardiography. Methods: A case-control observational study was conducted from January 2022 to August 2024 on 40 primary NS patients with steroid-resistant nephrotic syndrome (SRNS) and steroid-sensitive nephrotic syndrome (SSNS), alongside 40 healthy controls. All participants underwent RV assessments using conventional parameters, tissue Doppler imaging (TDI), two-dimensional speckle-tracking echocardiography (2D STE), and three-dimensional echocardiography (3DE). Results: Significantly lower s’, e’ in NS patients compared to controls, especially lower in SRNS compared to SSNS. Significantly higher E/e’ and Tei index was detected in the NS group compared to controls (p = < 0.001) and more pronounced in SRNS. RV free wall strain longitudinal strain (RVFWLS) and RV four chamber longitudinal strain (RV4CSL) were significantly reduced in NS group compared to controls. 3D auto RV-derived ejection fraction (EF), TAPSE, stroke volume and septal strain were lower in NS compared to controls(p = < 0.001); however, there are no significant differences between SSNS and SRNS. Significant correlations were detected between some echocardiographic parameters and serum cholesterol, albumin, and creatinine. Conclusions: Integrative use of variable echocardiographic modalities allows detection of subclinical alterations in RV function in children with primary NS, with more affected parameters in SRNS. Therefore, regular surveillance of RV functions in primary NS should be considered.
- Open Access
- 1 January 2026
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 11 (1) , 982
When Surgery Fails: The Role of Transcatheter Closure in Treating Giant Coronary Cameral Fistulas
- 1 January 2026
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 11 (1) , 982
Open AccessWhen Surgery Fails: The Role of Transcatheter Closure in Treating Giant Coronary Cameral Fistulas
- 23 December 2025
- Published by SAGE Publications in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
- Vol. 18
Diverse Vascular Manifestations of Takayasu Arteritis: Coronary Artery Stenosis and Aneurysmal Dilation in pediatric patients
Takayasu arteritis (TA) is a rare, chronic inflammatory disease that primarily affects large arteries, and in childhood (c-TA), it often presents with diverse and delayed manifestations that complicate diagnosis. We describe 2 pediatric cases that highlight the importance of early recognition and intervention. The first was a 3-month-old girl who presented with fever, respiratory distress, and peripheral cyanosis. Laboratory investigations revealed leukocytosis, anemia, elevated inflammatory markers, and hypercoagulability, while Doppler ultrasound and computed tomography angiography (CTA) demonstrated extensive vascular involvement with arterial occlusions and aneurysms. She was diagnosed with c-TA based on the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria and responded favorably to high-dose corticosteroids, infliximab, methotrexate, and antiplatelet therapy. The second case was a 17-year-old female with a history of hypertensive encephalopathy who presented with chest pain, arm numbness, and exertional dyspnea. Examination showed absent pulses and significant blood pressure discrepancies in the upper limbs, while laboratory tests revealed elevated erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and positive antinuclear antibody (ANA). The CTA confirmed severe stenosis and occlusions in multiple arteries, fulfilling the diagnostic criteria for TA. Despite treatment with sarilumab, corticosteroids, methotrexate, and antiplatelet therapy, she continued to experience symptoms and required further intervention. These cases underscore the need to consider TA in pediatric patients with hypertension, absent or diminished pulses, blood pressure discrepancies, limb claudication, chest pain, or unexplained systemic inflammatory symptoms. Early recognition and aggressive immunosuppressive therapy are essential to prevent irreversible vascular damage and improve long-term outcomes.
- 23 December 2025
- Published by SAGE Publications in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
- Vol. 18
Diverse Vascular Manifestations of Takayasu Arteritis: Coronary Artery Stenosis and Aneurysmal Dilation in pediatric patients
Takayasu arteritis (TA) is a rare, chronic inflammatory disease that primarily affects large arteries, and in childhood (c-TA), it often presents with diverse and delayed manifestations that complicate diagnosis. We describe 2 pediatric cases that highlight the importance of early recognition and intervention. The first was a 3-month-old girl who presented with fever, respiratory distress, and peripheral cyanosis. Laboratory investigations revealed leukocytosis, anemia, elevated inflammatory markers, and hypercoagulability, while Doppler ultrasound and computed tomography angiography (CTA) demonstrated extensive vascular involvement with arterial occlusions and aneurysms. She was diagnosed with c-TA based on the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria and responded favorably to high-dose corticosteroids, infliximab, methotrexate, and antiplatelet therapy. The second case was a 17-year-old female with a history of hypertensive encephalopathy who presented with chest pain, arm numbness, and exertional dyspnea. Examination showed absent pulses and significant blood pressure discrepancies in the upper limbs, while laboratory tests revealed elevated erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and positive antinuclear antibody (ANA). The CTA confirmed severe stenosis and occlusions in multiple arteries, fulfilling the diagnostic criteria for TA. Despite treatment with sarilumab, corticosteroids, methotrexate, and antiplatelet therapy, she continued to experience symptoms and required further intervention. These cases underscore the need to consider TA in pediatric patients with hypertension, absent or diminished pulses, blood pressure discrepancies, limb claudication, chest pain, or unexplained systemic inflammatory symptoms. Early recognition and aggressive immunosuppressive therapy are essential to prevent irreversible vascular damage and improve long-term outcomes.
- Open Access
- 4 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
The utility of novel echocardiographic techniques in evaluating cardiac function in patients undergoing hematopoietic stem cell transplantation: a pilot study
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for many refractory malignancies, bone marrow failure syndromes and primary immune deficiencies in children. Cardiomyopathy and heart failure are well described late complications of HSCT. By the time they manifest clinically, a significant and irreversible damage to the myocardium has occurred with resultant substantial morbidity and mortality. This study aims to evaluate subclinical cardiac affection by using conventional echocardiography, two-dimensional (2D) speckle tracking and three-dimensional (3D) Echo among patients before and after Hematopoietic Stem Cell Transplantation. A prospective case control study was conducted from 2022 to 2023 on 25 patients who underwent bone marrow transplantation and 25 controls. Demographic, clinical data were collected. Echocardiography was performed, including LV functional assessment using conventional echocardiography, 2D speckle tracking, and 3D echocardiography. The mean age of the patients was 9.8 years. Neuroblastoma was the most common indication for transplantation, accounting for 44% of cases, while only 4% of patients underwent transplantation for thalassemia. Significant changes were observed in fractional shortening (FS), global longitudinal strain (GLS), segmental myocardial strain parameters, and 3D ejection fraction (3D EF) before and after transplantation. FS showed a significant correlation with the cumulative dose of cyclophosphamide, while GLS average was significantly associated with disease duration, cumulative doses of cyclophosphamide, and doxorubicin. Additionally, 3D EF demonstrated significant correlations with these factors. GLS average, lateral longitudinal strain at the base, and 3D EF differed significantly between autologous and allogeneic transplant recipients. This study demonstrates significant changes in cardiac function following HSCT, with alterations in fractional shortening, global and segmental myocardial strain, and 3D ejection fraction. 3D echocardiography proved effective in detecting these changes.
- 4 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Open AccessThe utility of novel echocardiographic techniques in evaluating cardiac function in patients undergoing hematopoietic stem cell transplantation: a pilot study
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for many refractory malignancies, bone marrow failure syndromes and primary immune deficiencies in children. Cardiomyopathy and heart failure are well described late complications of HSCT. By the time they manifest clinically, a significant and irreversible damage to the myocardium has occurred with resultant substantial morbidity and mortality. This study aims to evaluate subclinical cardiac affection by using conventional echocardiography, two-dimensional (2D) speckle tracking and three-dimensional (3D) Echo among patients before and after Hematopoietic Stem Cell Transplantation. A prospective case control study was conducted from 2022 to 2023 on 25 patients who underwent bone marrow transplantation and 25 controls. Demographic, clinical data were collected. Echocardiography was performed, including LV functional assessment using conventional echocardiography, 2D speckle tracking, and 3D echocardiography. The mean age of the patients was 9.8 years. Neuroblastoma was the most common indication for transplantation, accounting for 44% of cases, while only 4% of patients underwent transplantation for thalassemia. Significant changes were observed in fractional shortening (FS), global longitudinal strain (GLS), segmental myocardial strain parameters, and 3D ejection fraction (3D EF) before and after transplantation. FS showed a significant correlation with the cumulative dose of cyclophosphamide, while GLS average was significantly associated with disease duration, cumulative doses of cyclophosphamide, and doxorubicin. Additionally, 3D EF demonstrated significant correlations with these factors. GLS average, lateral longitudinal strain at the base, and 3D EF differed significantly between autologous and allogeneic transplant recipients. This study demonstrates significant changes in cardiac function following HSCT, with alterations in fractional shortening, global and segmental myocardial strain, and 3D ejection fraction. 3D echocardiography proved effective in detecting these changes.
- Open Access
- 15 July 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 1-12
Left ventricular myocardial functions in pediatric patients with primary nephrotic syndrome: a comprehensive evaluation using conventional echocardiography, two-dimensional speckle tracking, and three-dimensional echocardiography
Background: Nephrotic syndrome (NS) has been linked to cardiac morbidity and mortality. However, early cardiac implications in NS were studied on a limited scale using basic echocardiography (ECHO). Therefore, the study aimed to evaluate subclinical Left ventricle (LV) functional alterations using conventional and advanced ECHO modalities. Methods: A prospective observational study was conducted from January 2022 to August 2024 on 40 primary NS patients and 40 controls. Demographic, clinical, and laboratory data were collected. ECHO was performed, including LV functional assessment using conventional ECHO, tissue Doppler, two-dimensional (2D) speckle tracking, and three-dimensional (3D) ECHO. Results: NS patients, whose mean age was 10.93 ± 2.78 years, were subclassified into steroid-sensitive NS (SSNS) 15(37.5%) and steroid-resistant NS (SRNS) 25 (62.5%). Compared with controls, there was no significant difference regarding conventional ejection fraction (EF) or E/A ratio. However, E/E’ ratio and tissue Doppler Tie index were significantly higher in NS ( p = 0.001, p= < 0.001, respectively), particularly SRNS. Average global longitudinal strain (GLS) was significantly lower in NS (p = < 0.001), especially SRNS, while 3D ECHO-measured EF significantly declined in NS (p = < 0.001). Tei index and E/E’ were moderately correlated with current cholesterol level, while E/E’ and GLS correlated with initial serum albumin. On regression analysis, current cholesterol and initial serum albumin were significant predictors for E/E’; p= 0.019 (ß: 0.014, 95% CI: 0.003–0.26) and p= 0.003 (ß:-1.41, 95% CI: -2.28- -0.53), respectively. No significant factors predicted GLS or 3D EF. Conclusion: In addition to diastolic subclinical LV dysfunction in children with primary NS detected using Tissue Doppler, systolic alterations could be detected using 2D speckle tracking or 3D ECHO. Some of the resultant subtle LV-impaired parameters could be correlated to NS-related biochemical changes.
- 15 July 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 1-12
Open AccessLeft ventricular myocardial functions in pediatric patients with primary nephrotic syndrome: a comprehensive evaluation using conventional echocardiography, two-dimensional speckle tracking, and three-dimensional echocardiography
Background: Nephrotic syndrome (NS) has been linked to cardiac morbidity and mortality. However, early cardiac implications in NS were studied on a limited scale using basic echocardiography (ECHO). Therefore, the study aimed to evaluate subclinical Left ventricle (LV) functional alterations using conventional and advanced ECHO modalities. Methods: A prospective observational study was conducted from January 2022 to August 2024 on 40 primary NS patients and 40 controls. Demographic, clinical, and laboratory data were collected. ECHO was performed, including LV functional assessment using conventional ECHO, tissue Doppler, two-dimensional (2D) speckle tracking, and three-dimensional (3D) ECHO. Results: NS patients, whose mean age was 10.93 ± 2.78 years, were subclassified into steroid-sensitive NS (SSNS) 15(37.5%) and steroid-resistant NS (SRNS) 25 (62.5%). Compared with controls, there was no significant difference regarding conventional ejection fraction (EF) or E/A ratio. However, E/E’ ratio and tissue Doppler Tie index were significantly higher in NS ( p = 0.001, p= < 0.001, respectively), particularly SRNS. Average global longitudinal strain (GLS) was significantly lower in NS (p = < 0.001), especially SRNS, while 3D ECHO-measured EF significantly declined in NS (p = < 0.001). Tei index and E/E’ were moderately correlated with current cholesterol level, while E/E’ and GLS correlated with initial serum albumin. On regression analysis, current cholesterol and initial serum albumin were significant predictors for E/E’; p= 0.019 (ß: 0.014, 95% CI: 0.003–0.26) and p= 0.003 (ß:-1.41, 95% CI: -2.28- -0.53), respectively. No significant factors predicted GLS or 3D EF. Conclusion: In addition to diastolic subclinical LV dysfunction in children with primary NS detected using Tissue Doppler, systolic alterations could be detected using 2D speckle tracking or 3D ECHO. Some of the resultant subtle LV-impaired parameters could be correlated to NS-related biochemical changes.
- Open Access
- 4 March 2024
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 3 (5) , 101355
Comparing Neurodevelopmental Outcomes in Infants With Patent Ductus Arteriosus Stenting Versus Blalock-Taussig-Thomas Shunt: A Pilot Study
- 4 March 2024
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 3 (5) , 101355
Open AccessComparing Neurodevelopmental Outcomes in Infants With Patent Ductus Arteriosus Stenting Versus Blalock-Taussig-Thomas Shunt: A Pilot Study
- 5 March 2023
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 14 (3) , 368-370
Surgical Mitral Valve Replacement Using a Catheter-Based MelodyTM Valve in a Landing Zone Constructed With a PTFE-Covered Expandable Cheatham-PlatinumTM Stent
Mitral valve replacement using a Melody valve is a promising solution to the challenge of surgical mitral valve replacement in infants with a hypoplastic annulus. We report the creation of a landing zone in the mitral valve annulus using a Cheatham-Platinum (CP)-covered stent that facilitates Melody valve placement, helps prevent paravalvular leak, minimizes left ventricular outflow tract obstruction, and allows for potential future dilation of the valve.
- 5 March 2023
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 14 (3) , 368-370
Surgical Mitral Valve Replacement Using a Catheter-Based MelodyTM Valve in a Landing Zone Constructed With a PTFE-Covered Expandable Cheatham-PlatinumTM Stent
Mitral valve replacement using a Melody valve is a promising solution to the challenge of surgical mitral valve replacement in infants with a hypoplastic annulus. We report the creation of a landing zone in the mitral valve annulus using a Cheatham-Platinum (CP)-covered stent that facilitates Melody valve placement, helps prevent paravalvular leak, minimizes left ventricular outflow tract obstruction, and allows for potential future dilation of the valve.